Australia's largest stock trading and investment forum Australia's #1 stock forum

PTX

Click for more information

0.00%

4.4¢ prescient therapeutics limited

Ann: June 2017 Appendix 4C - Quarterly, page-5

First 5 Last

Share
Profile

Follow
slc4me

4,306 Posts.

27/07/17

16:27

Post #: 26120820
Share

Originally posted by jonathan_2412 ↑

Won't be anytime soon IMO.

As this involves human death, the process will be extremely tedious.

They'll have to discuss internally to study the cause of death. From there deliberate on what changes has to be made to their internal protocol. Have to convene with internal human ethics commission before presenting to the FDA. After which the FDA will deliberate on it, and propose a recommendation or changes to be made based of the deliberation.

There isn't a set timeline and the management will not be able to confirm these information publicly yet, but my understanding with my close mate who is in this field has hinted that these things could take a longer time than what we have gone through before any confirmations are made.

It quite depends also on whether it was the drugs administered had any direct effect on the death. You could deduce that if they have found out that it is confirmed not to be the drugs, the process could be shortened.

Expand

Thanks for that. Guess its a bit like how long is a piece a string!

PTX Price at posting: 6.2¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What's causing the cost-of-living crisis, and how to navigate it

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

There are more pages in this discussion • 4 more messages in this thread...

First 5 Last

Add PTX (ASX) to my watchlist

(20min delay)
Last 4.4¢		Change 0.000(0.00%)		Mkt cap ! $35.43M

Open	High	Low	Value	Volume
4.4¢	4.4¢	4.4¢	$3.3K	75K

Buyers (Bids)

No.	Vol.	Price($)
2	282525	4.3¢

Sellers (Offers)

Price($)	Vol.	No.
4.6¢	13043	1

View Market Depth

No.	Vol.	Price($)
2	282525	0.043
3	82657	0.042
6	439000	0.041
9	1349510	0.040
1	10000	0.039

Price($)	Vol.	No.
0.046	13043	1
0.048	2664	1
0.049	70000	1
0.051	277227	2
0.053	112000	2

Last trade - 10.20am 18/10/2024 (20 minute delay)

PTX (ASX) Chart